Vertex Pharmaceuticals Inc / Ma

Erste Asset Management GmbH VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

67,363

Value ($000)

30,967

Weight

0.3%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	30,967	0.3%	67,363	12/31/2025
2025 Q3	11/12/2025	26,685	0.3%	67,517	9/30/2025
2025 Q2	8/14/2025	32,635	0.3%	73,903	6/30/2025
2025 Q1	5/14/2025	33,460	0.4%	68,770	3/31/2025
2024 Q4	2/10/2025	26,533	0.3%	65,774	12/31/2024
2024 Q3	11/14/2024	29,401	0.4%	63,514	9/30/2024
2024 Q2	11/26/2024	27,550	0.4%	58,306	6/30/2024
2024 Q1	11/26/2024	27,834	0.4%	66,698	3/31/2024
2023 Q4	11/26/2024	45,731	0.7%	111,931	12/31/2023
2023 Q3	11/26/2024	40,459	0.7%	115,225	9/30/2023
2023 Q2	11/26/2024	28,925	0.5%	83,075	6/30/2023
2023 Q1	11/26/2024	27,074	0.5%	86,730	3/31/2023
2022 Q4	11/26/2024	23,742	0.5%	82,130	12/31/2022
2022 Q3	11/26/2024	24,160	0.5%	82,523	9/30/2022
2022 Q2	11/26/2024	23,766	0.5%	84,773	6/30/2022
2022 Q1	11/25/2024	21,552	0.4%	84,000	3/31/2022
2021 Q4	11/25/2024	13,666	0.2%	61,200	12/31/2021
2021 Q3	11/25/2024	11,297	0.2%	62,000	9/30/2021
2021 Q2	11/25/2024	12,205	0.2%	62,000	6/30/2021
2021 Q1	11/25/2024	14,834	0.4%	69,640	3/31/2021
2020 Q4	11/25/2024	16,260	0.5%	69,640	12/31/2020
2020 Q3	11/25/2024	16,734	0.6%	61,902	9/30/2020
2020 Q2	11/22/2024	19,582	0.8%	68,650	6/30/2020
2020 Q1	11/22/2024	21,203	1.2%	91,400	3/31/2020
2019 Q4	11/22/2024	18,096	0.8%	81,900	12/31/2019
2019 Q3	11/22/2024	35,683	1.9%	211,900	9/30/2019
2019 Q2	11/22/2024	40,138	2.1%	221,000	6/30/2019
2019 Q1	11/22/2024	37,191	2.1%	202,700	3/31/2019
2018 Q4	11/26/2024	35,377	2.4%	218,700	12/31/2018